Sydney Jennings

Articles

Omalizumab Beats OIT in First Head-to-Head Multi-Food Allergy Trial: Daily Dose

March 28, 2025

Your daily dose of the clinical news you may have missed.

April Issue of Patient Care Digital Edition is Now Live

March 27, 2025

The April issue covers atopic dermatitis, highlighting primary care’s role in early diagnosis, key updates from recent conferences, and more.

Decline in Smoking Averted Nearly 4 Million Lung Cancer Deaths in the US, Study Estimates

March 27, 2025

The number of lung cancer deaths averted represents more than 51% of the expected reduction in total cancer deaths, researchers reported.

Better CV Health Tied to Lower Neurodegeneration Risk: Daily Dose

March 27, 2025

Your daily dose of the clinical news you may have missed.

Underutilization of Guideline-Recommended Epinephrine in Anaphylaxis Management: New Study

March 26, 2025

A 5-year study conducted in Germany showed only 7% of adults and 8% of children with severe anaphylaxis received epinephrine.

Sanofi's Chlamydia Vaccine Granted FDA Fast Track Designation

March 26, 2025

The FDA granted fast track designation to Sanofi’s chlamydia vaccine candidate today, aiming to prevent infections and address an unmet public health need.

Delgocitinib Cream Shows "Super Response" in Chronic Hand Eczema: Daily Dose

March 26, 2025

Your daily dose of the clinical news you may have missed.

FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs

March 25, 2025

Gepotidacin is the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, offering an alternative amid rising antibiotic resistance.

Maternal Mortality Due to Cardiovascular Disease More Than Doubles in the US

March 25, 2025

ACC 2025: Black women and women in Southern states faced significantly higher rates of maternal mortality, according to a new study.

OX40 Inhibitor Rocatinlimab Found Effective for Atopic Dermatitis: Daily Dose

March 25, 2025

Your daily dose of the clinical news you may have missed.